Finance

Lists
FRX:TSE
Fennec Pharmaceuticals Inc
14,86 CAD
0,00%
(0,00) 1D
7-окт., 12:46:18 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for FRX...
Mkt. cap
535,20 млн
Avg. vol.
476,00
Volume
0,00
52-wk high
17,64 CAD
52-wk low
7,59 CAD
EPS
-0,17 CAD
Beta
1,05
Shares outstanding
35,07 млн
No. of employees
35
Mkt. cap
535,20 млн
Avg. vol.
476,00
Volume
0,00
52-wk high
17,64 CAD
52-wk low
7,59 CAD
EPS
-0,17 CAD
Beta
1,05
Shares outstanding
35,07 млн
No. of employees
35
News stories
From web sources and news partners
About Fennec Pharmaceuticals Inc
CEO-
Employees35
Founded1996
HeadquartersДарем, Север Каролина, Америка Кошмо Штаттары
Sector-
Websitefennecpharma.com
Last report
2026-ж., 11-авг.
Fiscal period
Q2 2026
- / 0,02 USD
Revenue / Est. (USD)
17,87 млн / 16,12 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
12,46 млн
13,78 млн
15,11 млн
17,87 млн
Cost of goods sold
660,00 миң
1,76 млн
570,00 миң
721,00 миң
Cost of revenue
660,00 миң
1,76 млн
570,00 миң
721,00 миң
Research and development expenses
29,00 миң
20,00 миң
49,00 миң
118,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,96 млн
14,55 млн
14,61 млн
15,30 млн
Operating expense
11,99 млн
14,57 млн
14,66 млн
15,42 млн
Total operating expenses
12,65 млн
16,33 млн
15,23 млн
16,14 млн
Operating income
-189,00 миң
-2,55 млн
-119,00 миң
1,74 млн
Other non operating income
-
-
-
-
EBT including unusual items
-638,00 миң
-4,68 млн
201,00 миң
2,02 млн
EBT excluding unusual items
-638,00 миң
-2,66 млн
201,00 миң
2,02 млн
Income tax expense
-
106,00 миң
-
42,00 миң
Effective tax rate
-
-2,26%
-
2,08%
Other operating expenses
-
-
-
-
Net income
-638,00 миң
-4,79 млн
201,00 миң
1,97 млн
Net profit margin
-5,12%
-34,75%
1,33%
11,04%
Earnings per share
-0,02
-0,10
-
-
Interest and investment income
152,00 миң
228,00 миң
339,00 миң
287,00 миң
Interest expense
-598,00 миң
-334,00 миң
-7,00 миң
-3,00 миң
Net interest expenses
-446,00 миң
-106,00 миң
332,00 миң
284,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-163,00 миң
-2,53 млн
-93,00 миң
1,76 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору